Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 388, Issue 6, 2015, Pages 635-641

  Kansal, Sunil Kumar ^a   Jyoti, Uma ^a   Sharma, Samridhi ^a   Kaura, Arun ^a   Deshmukh, Rahul ^b   Goyal, Sandeep ^a  

^a BABA FARID UNIVERSITY OF HEALTH SCIENCES   (India)

^b ISF COLLEGE OF PHARMACY   (India)

Author keywords

Collagen; Hyperlipidemia; Ischemic preconditioning; Zinc chelator; Zinc ionophore

Indexed keywords

COLLAGEN; CREATINE KINASE MB; IONOPHORE; LACTATE DEHYDROGENASE; PYRITHIONE ZINC; TRIPHENYLTETRAZOLIUM; CARDIOTONIC AGENT; ETHYLENEDIAMINE DERIVATIVE; LIPID; N,N,N',N'-TETRAKIS(2-PYRIDYLMETHYL)ETHYLENEDIAMINE; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HYPERLIPIDEMIA; ISCHEMIC PRECONDITIONING; LIPID DIET; MALE; NONHUMAN; RAT; REPERFUSION; ANIMAL; BLOOD; DIET SUPPLEMENTATION; HEART INFARCTION PREVENTION; HEART MUSCLE; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CARDIOTONIC AGENTS; COLLAGEN; CREATINE KINASE, MB FORM; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; ETHYLENEDIAMINES; FEMALE; HYPERLIPIDEMIAS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; LIPIDS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS, WISTAR; ZINC;

EID: 84929947797     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-015-1105-6     Document Type: Article

References (37)

1. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475
2. Antman EM, Braunwald E (1997) Acute myocardial infarction. In: Braunwald E (ed) Heart disease, a textbook of cardiovascular medicine, 5th edn. WB Saunders & Co, Philadelphia, pp 1184-1188
3. Bray TM, Bettger WJ (1990) The physiological role of zinc as an antioxidant. Free Radic Biol Med 8:281-291
4. Buja LM (2005) Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 14:170-175
5. Chanoit G, Lee S, Xi J, Zhu M, McIntosh RA, Mueller RA, Norfleet EA, Xu Z (2008) Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3β. Am J Physiol 295:H1227-H1233
6. Chopra K, Singh M, Kaul N, Andrabi KJ, Ganguly NK (1992) Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect. Mol Cell Biochem 113:71-76
7. Collard CD, Gelman S (2001) Pathophysiology, clinical manifestation and prevention of ischemic reperfusion injury. Anesthesiology 94:1133-1138
8. Csont T, Bereczki E, Bencsik P, Fodor G, Gorbe A, Zvara A, Csonka C, Puskas IG, Santha M, Ferdinandy P (2007) Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice. Cardiovasc Res 76:100-109
9. Ferdinandy P (2003) Myocardial ischemia/reperfusion injury and preconditioning: effects of hypercholesterolemia/hyperlipidemia. Br J Pharmacol 138:283-285
10. Ferdinandy P, Szilvassy Z, Baxter GF (1998) Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci 19:223-229
11. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Merair JC, Corday E, Ganz W (1981) Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 101:593-600
12. Fryer RM, Pratt PF, Hsu AK, Gross GJ (2001) Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 296:642-649
13. Giricz Z, Lalu MM, Csonka C, Bencsik P, Schulz R, Ferdinandy P (2006) Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition. J Pharmacol Exp Ther 316:154-161
14. Hausenloy DJ, Duchen MR, Yellow DM (2003) Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischemia-reperfusion injury. Cardiovasc Res 60:617-625
15. Hoshida S, Yamashita N, Igarashi J, Nishida M, Hori M, Kuzuya T, Tada M (1996) A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia. J Pharmacol Exp Ther 278:741-746
16. Iliodromitis KE, Lazou A, Kremastinos DT (2007) Ischemic preconditioning: protection against myocardial necrosis and apoptosis. Vasc Health Risk Manag 3:629-637
17. Jamall IS, Finelli VN, Que Hee SS (1981) A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 112:70-75
18. Jung O, Jung W, Malinski T, Wiemer G, Schoelkens BA, Linz W (2000) Ischemic preconditioning and infarct mass: effect of hypercholesterolemia and endothelial dysfunction. Clin Exp Hypertens 22:165-179
19. Karagulova G, Yue Y, Moreyra A, Boutjdir M, Korichneva I (2007) Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther 321:517-525
20. Katakam PVG, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW (2007) Myocardial preconditioning against ischemia-reperfusion injury is in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 292:920-926
21. Kurose I, Argenbright LW, Anderson DC, Tolley J, Miyasaka M, Harris N, Granger DN (1997) Reperfusion-induced leukocyte adhesion and vascular protein leakage in normal and hypercholesterolemia rats. Am J Physiol 273:H854-H860
22. Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL (2010) Zinc and cardiovascular disease. Nutrition 26:1050-1057
23. McIntosh R, Lee S, Ghio AJ, Xi J, Zhu M, Shen X (2010) The critical role of intracellular zinc in adenosine A2 receptor activation induced cardioprotection against reperfusion injury. J Mol Cell Cardiol 49:41-47
24. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
25. Nakamura M, Wang NP, Zhao ZQ, Wilcox JN, Thourani V, Guyton RA, Vinten-Johansen J (2000) Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 45:661-670
26. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG (1995) Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 92:898-903
27. Onody A, Csonka C, Giricz Z, Ferdinandy P (2003) Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrate formation in rat hearts. Cardiovasc Res 58:663-670
28. Parikh V, Singh M (1999) Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning induced cardioprotection. Pharmacol Res 40:129-137
29. Puskas LG, Nagy ZB, Giricz Z, Onody A, Csonka C, Kitajka K (2004) Cholesterol diet induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microassay study. FEBS Lett 562:99-104
30. Sharma A, Singh M (2000) Possible mechanism of cardioprotective effect of ischaemic preconditioning in isolated rat heart. Pharmacol Res 41:635-640
31. Sharma NK, Mahadevan N, Balakumar P (2013) Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: potential crosstalk with opioid receptors. Cardiovasc Toxicol 13:22-32
32. Tyagi P, Tayal G (2002) Ischemic preconditioning of myocardium. Acta Pharmacol Sin 23:865-870
33. Ungi I, Ungi T, Ruzsa Z, Nagy E, Zimmermann Z, Csont T, Ferdinandy P (2005) Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty. Chest 128:1623-1628
34. ATP channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide. J Mol Cell Cardiol 33:2037-2046
35. Wang TD, Chen WJ, Seh-Yi SS, Lo SC, Lin WW, Lee YT (2002) Increased cardiomyocyte apoptosis following ischemia and reperfusion in diet induced hypercholesterolemia: relation of Bcl-2 and Bax proteins and caspase-3 activity. Lipids 37:385-394
36. Werner M, Gabrielson DG, Eastman J (1981) Ultramicro determination of serum triglycerides by bioluminescent assay. Clin Chem 27:268-271
37. Xu Z, Kim S, Hua J (2014) Zinc plays a critical role in the cardioprotective effect of postconditioning by enhancing the activation of the RISK pathway in rat hearts. J Mol Cell Cardiol 66:12-17